By Patrick D Hahn —— Bio and Archives--December 16, 2020
Peter Doshi is an Associate Professor of Pharmaceutical Health Services at the University of Maryland, an Associate Editor at the BMJ, and a leading advocate for clinical trial transparency.
In a November 26 editorial in the BMJ, Dr. Doshi noted that we still don't know whether the vaccine saves lives or prevents transmission of the disease to others. Moreover, he argued that without access to the patient-level data, we don't even really know whether the vaccine has any efficacy regarding the primary endpoint of the trial, which is Covid-19 infection of any severity.
Related Series:
• Hope or Hype: Part 1: How Effective is the Covid Vaccine?
• Hope or Hype: Part 2: How Safe is the Covid Vaccine?The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy
Support Canada Free Press
